Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
Autor: | Masi, Gianluca, Loupakis, Fotios, Salvatore, Lisa, Fornaro, Lorenzo, Cremolini, Chiara, Cupini, Samanta, Ciarlo, Andrea, Del Monte, Francesca, Cortesi, Enrico, Amoroso, Domenico, Granetto, Cristina, Fontanini, Gabriella, Sensi, Elisa, Lupi, Cristiana, Andreuccetti, Michele, Falcone, Alfredo |
---|---|
Zdroj: | In The Lancet Oncology September 2010 11(9):845-852 |
Databáze: | ScienceDirect |
Externí odkaz: |